Cleared Traditional

K200898 - Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas Glucose, Medicon Hellas Total Bilirubin, Medicon Hellas Direct Bilirubin (FDA 510(k) Clearance)

Sep 2021
Decision
536d
Days
Class 2
Risk

K200898 is an FDA 510(k) clearance for the Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas Glucose, Medicon Hellas Total Bilirubin, Medicon Hellas Direct Bilirubin. This device is classified as a Bromcresol Green Dye-binding, Albumin (Class II - Special Controls, product code CIX).

Submitted by Medicon Hellas S.A (Gerakas, GR). The FDA issued a Cleared decision on September 21, 2021, 536 days after receiving the submission on April 3, 2020.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1035.

Submission Details

510(k) Number K200898 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2020
Decision Date September 21, 2021
Days to Decision 536 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CIX - Bromcresol Green Dye-binding, Albumin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1035